Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
2002 1
2008 3
2009 2
2010 8
2011 3
2012 5
2013 11
2014 10
2015 8
2016 14
2017 9
2018 8
2019 11
2020 11
2021 11
2022 8
2023 8
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for male chlosta
Your search for Malte Chlosta retrieved no results
Alpha emitter radium-223 and survival in metastatic prostate cancer.
Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, Bottomley D, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Coleman R, Vogelzang NJ, O'Bryan-Tear CG, Staudacher K, Garcia-Vargas J, Shan M, Bruland ØS, Sartor O; ALSYMPCA Investigators. Parker C, et al. N Engl J Med. 2013 Jul 18;369(3):213-23. doi: 10.1056/NEJMoa1213755. N Engl J Med. 2013. PMID: 23863050 Free article. Clinical Trial.
Current interventional management of male stress urinary incontinence following urological procedures.
Ostrowski I, Śledź E, Ciechan J, Golabek T, Bukowczan J, Przydacz M, Wiatr T, Stangel-Wojcikiewicz K, Chłosta PL. Ostrowski I, et al. Cent European J Urol. 2015;68(3):340-7. doi: 10.5173/ceju.2015.616. Epub 2015 Sep 26. Cent European J Urol. 2015. PMID: 26568879 Free PMC article. Review.
Male slings and adjustable continence devices, achieve the social continence rates up to 60%. Periurethral injections of bulking agents, have limited efficacy of male stress incontinence. Argus sling and ProACT are both associated with substantial explantation rates …
Male slings and adjustable continence devices, achieve the social continence rates up to 60%. Periurethral injections of bulking agen …
Testosterone replacement therapy in obese males.
Drewa T, Olszewska-Słonina D, Chlosta P. Drewa T, et al. Acta Pol Pharm. 2011 Sep-Oct;68(5):623-7. Acta Pol Pharm. 2011. PMID: 21928705 Free article. Review.
Controversy surrounds testosterone replacement therapy in obese ageing due to no generally accepted lower limits of normal testosterone level and high prevalence of hypogonadal symptoms in the ageing male population and the non-specific nature of these symptoms. Late onset …
Controversy surrounds testosterone replacement therapy in obese ageing due to no generally accepted lower limits of normal testosterone leve …
Penile Fracture: A Meta-Analysis.
Amer T, Wilson R, Chlosta P, AlBuheissi S, Qazi H, Fraser M, Aboumarzouk OM. Amer T, et al. Urol Int. 2016;96(3):315-29. doi: 10.1159/000444884. Epub 2016 Mar 9. Urol Int. 2016. PMID: 26953932 Free article.
How to assess and predict success or failure of intra-detrusor injections with onabotulinumtoxinA.
Przydacz M, Golabek T, Chlosta P. Przydacz M, et al. Adv Clin Exp Med. 2019 Apr;28(4):555-567. doi: 10.17219/acem/90764. Adv Clin Exp Med. 2019. PMID: 30729759 Free article. Review.
Potential risk factors that may influence the treatment outcomes include urodynamically proven detrusor overactivity, elevated maximum detrusor pressure, greater maximum cystometric capacity, impaired bladder compliance, older age, male gender, a higher baseline bother sco …
Potential risk factors that may influence the treatment outcomes include urodynamically proven detrusor overactivity, elevated maximum detru …
Testosterone measurement in patients with prostate cancer.
Schulman CC, Irani J, Morote J, Schalken JA, Montorsi F, Chlosta PL, Heidenreich A. Schulman CC, et al. Eur Urol. 2010 Jul;58(1):65-74. doi: 10.1016/j.eururo.2010.04.001. Eur Urol. 2010. PMID: 20434831 Review.
Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study.
Khadhouri S, Gallagher KM, MacKenzie KR, Shah TT, Gao C, Moore S, Zimmermann EF, Edison E, Jefferies M, Nambiar A, Anbarasan T, Mannas MP, Lee T, Marra G, Gómez Rivas J, Marcq G, Assmus MA, Uçar T, Claps F, Boltri M, La Montagna G, Burnhope T, Nkwam N, Austin T, Boxall NE, Downey AP, Sukhu TA, Antón-Juanilla M, Rai S, Chin YF, Moore M, Drake T, Green JSA, Goulao B, MacLennan G, Nielsen M, McGrath JS, Kasivisvanathan V; IDENTIFY Study Group. Khadhouri S, et al. Eur Urol Focus. 2022 Nov;8(6):1673-1682. doi: 10.1016/j.euf.2022.06.001. Epub 2022 Jun 25. Eur Urol Focus. 2022. PMID: 35760722 Free article.
The final model included predictors of increased risk (visible haematuria, age, smoking history, male sex, and family history) and reduced risk (previous haematuria investigations, urinary tract infection, dysuria/suprapubic pain, anticoagulation, catheter use, and previou …
The final model included predictors of increased risk (visible haematuria, age, smoking history, male sex, and family history) and re …
118 results